🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-521595-55-00
Completed Phase I

Investigating how NNC0487-0111 regulates insulin in adults with type 2 diabetes

2025-521595-55-00 · tracked via the Priya Life Science EU tracker
Sponsor
Novo Nordisk A/S
Sponsor type
Pharmaceutical company
Therapeutic area
Nutritional and Metabolic Diseases
Decision date
09/03/2026
Enrollment target
80
Sites
Germany

Condition studied

Type 2 Diabetes

Eligibility

Age group
65+ years, 18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-521595-55-00 on CTIS ↗ ← All trials in the EU